Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filedfiledCritical
Priority to ECSP982591priorityCriticalpatent/ECSP982591A/en
Publication of ECSP982591ApublicationCriticalpatent/ECSP982591A/en
Acyclic And Carbocyclic Compounds In Medicinal Compositions
(AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines
(AREA)
Abstract
Un método para el tratamiento de la diabetes mellitus y las condiciones asociadas con la diabetes mellitus en un mamífero, método que comprende administrar una cantidad efectiva, no tóxica y farmacéuticamente aceptable de un sensibilizador de insulina, un secretagogo de insulina y un agente antihiperglucémico del tipo biguanida, a un mamífero que lo necesite, y una composición para empleo en dicho método.A method for the treatment of diabetes mellitus and the conditions associated with diabetes mellitus in a mammal, which method comprises administering an effective, non-toxic and pharmaceutically acceptable amount of an insulin sensitizer, an insulin secretagogue and an antihyperglycemic agent of the type biguanide, to a mammal in need, and a composition for use in said method.
ECSP9825911998-07-161998-07-16
NEW METHOD OF TREATMENT IV
ECSP982591A
(en)
USE OF AN INSULIN SENSITIZER AND AN ANTI-HYPERGLYCEMIC AGENT FOR THE PREPARATION OF A MEDICATION FOR THE TREATMENT OF DIABETES MELLITUS AND CONDITIONS ASSOCIATED WITH IT AND A PHARMACEUTICAL COMPOSITION.